Crossmark

Cost-effectiveness study of early versus late parenteral nutrition in critically ill children (PEPaNIC): preplanned secondary analysis of a multicentre randomised controlled trial

Crossref DOI link: https://doi.org/10.1186/s13054-017-1936-2

Published Online: 2018-01-15

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

van Puffelen, Esther

Polinder, Suzanne

Vanhorebeek, Ilse

Wouters, Pieter Jozef

Bossche, Niek

Peers, Guido

Verstraete, Sören

Joosten, Koen Felix Maria

Van den Berghe, Greet

Verbruggen, Sascha Cornelis Antonius Theodorus

Mesotten, Dieter
Funding

Funding for this research was provided by:

Agentschap voor Innovatie door Wetenschap en Technologie (IWT-TBM110685)

Anonymous Dutch family (private donation)

Fonds Wetenschappelijk Onderzoek (METH/08/07)

Fonds Wetenschappelijk Onderzoek (METH/14/06)

FP7 Ideas: European Research Council (321670)

Fonds NutsOhra

Erasmus Medisch Centrum (Cost-Effectiveness Research Grant)

Vereniging Trustfonds Erasmus Universiteit Rotterdam
More Information

Article History

Received: 18 August 2017

Accepted: 27 December 2017

First Online: 15 January 2018

Ethics approval and consent to participate

: The institutional ethical review boards of the participating centres in Leuven (ML8052), Rotterdam (NL38772.000.12) and Edmonton (Pro00038098) approved the study, which was performed in accordance with the 1964 Declaration of Helsinki and its amendments. Written informed consent was obtained from the parents or legal guardians.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below